CRF1 and ACTH inhibitors are a promising approach to treat obesity and leptin and insulin resistance.
Saved in:
| Title: | CRF1 and ACTH inhibitors are a promising approach to treat obesity and leptin and insulin resistance. |
|---|---|
| Authors: | Contreras PH; Reproductive Health Research Institute, Santiago, Chile., Falhammar H; Department of Endocrinology, Karolinska University Hospital, Stockholm, Sweden.; Department of Molecular Medicine, Karolinska Institutet, Stockholm, Sweden. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2025 Sep 25; Vol. 16, pp. 1647028. Date of Electronic Publication: 2025 Sep 25 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-2392 |
|---|---|
| DOI: | 10.3389/fendo.2025.1647028 |
